Total Funding
63
71
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49852
Acelot is a biopharmaceutical company that provides therapies for nervous system disorders.
- Katie Planey: Chief Executive OfficerPast Role: Mantra Bio, Co-Founder and CTO
About the Company
Acelot is a life science-based R&D company on advanced technology for drug discovery. This technology is made available as a web-based drug discovery platform, employed in-house for some drug-discovery projects in the central nervous system area. It allows the identification of latent pharmacophore information and can be used for rapid
identification and optimization of drug development projects without clear target information or crystallography data.
